Forum: uniQure » Analisten over UniQure » Pagina: 12 | Beursduivel.be

Analisten over UniQure

229 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 12 | Laatste
Aantal posts per pagina:  20 50 100 | Omlaag ↓
Beurs2019
0
quote:

pim f schreef op 18 apr 2019 om 09:21:


highlightpress.com/2019/04/17/uniqure...

1x Sell, 1x Hold en 12x Buy en de kop is "Sell". Highlight Press heeft voor mij afgedaan !
Tex Mex
1
Toe maar: Chardan analyst Gbola Amusa raised his price target for uniQure (QURE) to $175 from $100 to reflect the company's opportunity in Huntington's disease.

twitter.com/zbiotech/status/112903186...
pim f
0
quote:

Tex Mex schreef op 16 mei 2019 om 16:58:


Chardan analyst Gbola Amusa raised his price target for uniQure (QURE) to $175 from $100 to reflect the company's opportunity in Huntington's disease.


Hoppa, niet van dat benauwde gepriegel
pim f
0
quote:

Tex Mex schreef op 16 mei 2019 om 16:58:


Toe maar: Chardan analyst Gbola Amusa raised his price target for uniQure (QURE) to $175 from $100 to reflect the company's opportunity in Huntington's disease.

twitter.com/zbiotech/status/112903186...


Chardan Capital Reiterates a Buy Rating on uniQure NV (QURE)
May 16, 2019

Amusa noted: "We believe uniQure, a 2019, could be en route to $5-10bn valuation, based on support in the coming year from what could be a best-in-class, breakthrough Huntington's disease (HD) franchise. HD is a universally fatal monogenic (autosomal dominant) disease that usually starts between ages 30 and 50, followed by movement, cognitive, and psychiatric impairment. Death typically follows 10 to 30 years after diagnosis. In 2H19, uniQure is expected to make AAV5-based gene therapy (GT), AMT-130, the first 1-time GT to enter the clinic for HD. AMT-130 utilizes uniQure's miQURE silencing technology to inhibit the production of the mutant huntingtin protein (mHTT).

www.markets.co/chardan-capital-reiter...
Prof. Dollar
0
Prof. Dollar
0
quote:

Prof. Dollar schreef op 17 mei 2019 om 14:28:


Video van corporate update uniQure gegeven eind april door Jon Garen, Chief Business Officer. TNX flosz
www.youtube.com/watch?v=WMt2Afh_Wgc

Ah, had ik eigenlijk in ander draadje willen plaatsen... het zij zo.
pim f
0
Brokerages Set Uniqure NV (QURE) Price Target at $75.89

Posted by Brian Wu on May 18th, 2019

Uniqure logoUniqure NV (NASDAQ:QURE) has been assigned an average rating of “Buy” from the fourteen research firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $77.22.

Several research analysts have weighed in on QURE shares. Zacks Investment Research upgraded Uniqure from a “sell” rating to a “hold” rating in a research report on Thursday, January 17th. SunTrust Banks increased their price objective on Uniqure to $76.00 and gave the stock a “buy” rating in a research report on Tuesday. BidaskClub upgraded Uniqure from a “sell” rating to a “hold” rating in a research report on Tuesday. Robert W. Baird started coverage on Uniqure in a research report on Thursday, March 28th. They set an “outperform” rating and a $85.00 price objective on the stock. Finally, HC Wainwright reiterated a “buy” rating on shares of Uniqure in a research report on Tuesday, February 26th.

mayfieldrecorder.com/2019/05/18/broke...
229 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 12 | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Plaats een reactie

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

BEL 20 3.472,34 0,00 0,00% 24 mei
BRX20-24h 3.484,12 +11,78 +0,34% 08:57
BEL 20 GR 9.659,41 0,00 0,00% 24 mei
BEL Mid 5.301,26 0,00 0,00% 24 mei
AEX 547,21 0,00 0,00% 24 mei
AMS25-24h 549,68 +2,47 +0,45% 08:57
Dutch15-index 15.401,27 0,00 0,00% 24 mei
France40# 5.346,45 +29,94 +0,56% 08:57
Germany30^ 12.074,00 +62,96 +0,52% 08:57
Europe50^ 3.369,66 +18,96 +0,57% 08:57
Euro30-index 17.219,25 0,00 0,00% 24 mei
Nasd100# 7.314,69 +13,73 +0,19% 08:57
Japan225# 21.230,44 +113,22 +0,54% 08:57
US30# 25.658,83 +80,53 +0,31% 08:57
Brent Crude Oi... 69,24 +1,48 +2,18% 24 mei
Gold World Spo... 1.285,79 +0,84 +0,07% 08:57
EUR/USD 1,1203 -0,0007 -0,06% 08:57
US500# 2.833,87 +5,92 +0,21% 08:57
WTI Crude Oil ... 58,39 +0,48 +0,83% 06:13

Stijgers & Dalers

Stijgers Laatst +/- % tijd
AB InBev 73,530 0,000 0,00% 24 mei
Ackermans & v.H 136,700 0,000 0,00% 24 mei
Ageas 45,160 0,000 0,00% 24 mei
Dalers Laatst +/- % tijd
AB InBev 73,530 0,000 0,00% 24 mei
Ackermans & v.H 136,700 0,000 0,00% 24 mei
Ageas 45,160 0,000 0,00% 24 mei

Brussel real time stocks quotedata by Euronext. Other real time EU stocks, by Cboe Europe Ltd.; US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
# calculated realtime by Commerzbank & '^' by BNP Paribas, streaming powered by VWD Group